IRadimed Corporation (IRMD) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
IRMD Revenue Growth
Revenue Breakdown (FY 2025)
IRMD's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
IRMD Revenue Analysis (2014–2025)
As of May 8, 2026, IRadimed Corporation (IRMD) generated trailing twelve-month (TTM) revenue of $86.3 million, reflecting strong growth of +12.7% year-over-year. The most recent quarter (Q1 2026) recorded $22.0 million in revenue, down 3.1% sequentially.
Looking at the longer-term picture, IRMD's 5-year compound annual growth rate (CAGR) stands at +21.5%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $83.8 million in 2025, representing a new all-time high.
Revenue diversification analysis shows IRMD's business is primarily driven by MRI Compatible Patient Vital Signs Monitoring Systems (100%). With over half of revenue concentrated in MRI Compatible Patient Vital Signs Monitoring Systems, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including LNTH (+0.6% YoY), PRCT (+29.3% YoY), and ANGO (+7.3% YoY), IRMD has underperformed the peer group in terms of revenue growth. Compare IRMD vs LNTH →
IRMD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| IRMDCurrent | $86M | +12.7% | +21.5% | 31.2% | |
 LNTH | $1.5B | +0.6% | +35.3% | 20.2% | |
 PRCT | $308M | +29.3% | +109.0% | -33.7% | |
 ANGO | $292M | +7.3% | +2.1% | -13.7% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 GEHC | $20.6B | +0.8% | +3.7% | 13.4% |
IRMD Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $83.8M | +14.4% | $64.3M | 76.7% | $26.1M | 31.2% |
| 2024 | $73.2M | +11.7% | $56.3M | 76.9% | $22.0M | 30.0% |
| 2023 | $65.6M | +23.0% | $50.2M | 76.5% | $20.0M | 30.6% |
| 2022 | $53.3M | +27.5% | $41.3M | 77.4% | $15.6M | 29.3% |
| 2021 | $41.8M | +31.8% | $32.0M | 76.6% | $9.8M | 23.5% |
| 2020 | $31.7M | -17.7% | $23.6M | 74.3% | $-756,091 | -2.4% |
| 2019 | $38.5M | +26.5% | $29.7M | 77.1% | $8.6M | 22.5% |
| 2018 | $30.4M | +31.9% | $23.2M | 76.3% | $6.0M | 19.7% |
| 2017 | $23.1M | -29.0% | $17.5M | 75.9% | $1.3M | 5.6% |
| 2016 | $32.5M | +2.9% | $26.3M | 81.1% | $10.9M | 33.6% |
See IRMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IRMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IRMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIRMD — Frequently Asked Questions
Quick answers to the most common questions about buying IRMD stock.
Is IRMD's revenue growth accelerating or slowing?
IRMD maintains +12.7% revenue growth, in line with its 5-year CAGR of +21.5%. TTM revenue stands at $86M. Growth rate remains consistent with historical average.
What is IRMD's long-term revenue growth rate?
IRadimed Corporation's 5-year revenue CAGR of +21.5% reflects the sustained expansion pattern. Current YoY growth of +12.7% is near this long-term average.
How is IRMD's revenue distributed by segment?
IRMD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.